Search

everythinglearnresearchcommunity

for

Search:↓

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Csdc2 helps hair growth in cashmere goats by regulating specific genes.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

CXCR2 in skin cells promotes tumor growth.

p63 and p73 regulate the vitamin D receptor, affecting cancer cell behavior and vitamin D sensitivity.

Soluble CD83 speeds up wound healing and reduces scarring.

CTHRC1 helps sweat glands recover by rebuilding nearby blood vessels.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

New mutations in the EBP gene cause CDPX2, affecting bones, skin, eyes, and hair, with females generally less affected than males.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

3D cell cultures produce extracellular vesicles similar to those in the body.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Mutations in claudin-1 and claudin-3 cause hair loss in baby mice.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Blocking certain immune signals can reduce skin damage from radiation therapy.

CAP1 decreases the expression of a hair-related protein in young Tan sheep's skin.

Genetic variants in specific genes cause central centrifugal cicatricial alopecia.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

The PER3 rs772027021 SNP may cause mild skin pigmentation changes in a new subtype of dyschromatosis universalis hereditaria.

Boosting β-catenin signaling in certain skin cells can enhance hair growth.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

The assay effectively identifies compounds that affect immune cell activation.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Targeting EGFR may help reduce hair loss from chemotherapy.